Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.

[1]  D. Tyler,et al.  In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy , 2015, Annals of Surgical Oncology.

[2]  K. Shannon,et al.  In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy , 2015, Annals of Surgical Oncology.

[3]  P. Queirolo,et al.  The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma. , 2014, Anticancer research.

[4]  A. Halpern,et al.  Melanoma, version 4.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  D. Tyler,et al.  Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma. , 2014, Journal of the American College of Surgeons.

[6]  A. Mansfield,et al.  In-transit melanoma: an individualized approach. , 2011, Oncology.

[7]  B. Pockaj,et al.  Risk factors associated with local and in-transit recurrence of cutaneous melanoma. , 2010, American journal of surgery.

[8]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[9]  I. V. D. van der Ploeg,et al.  Is Completion Lymph Node Dissection Needed in Case of Minimal Melanoma Metastasis in the Sentinel Node? , 2009, Annals of surgery.

[10]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[11]  D. Morton,et al.  Is Sentinel Lymph Node Mapping Indicated for Isolated Local and In-Transit Recurrent Melanoma? , 2003, Annals of surgery.

[12]  R. Elashoff,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma: Therapeutic Utility and Implications of Nodal Microanatomy and Molecular Staging for Improving the Accuracy of Detection of Nodal Micrometastases , 2003, Annals of surgery.

[13]  M. Ross,et al.  Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Balch,et al.  Factors affecting survival following local, regional, or distant recurrence from localized melanoma , 1998, Journal of surgical oncology.

[15]  S. Swisher,et al.  Natural history and selective management of in transit melanoma , 1990, Journal of surgical oncology.

[16]  T. Pawlik,et al.  Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy , 2006, Annals of Surgical Oncology.

[17]  C. Balch,et al.  Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial , 2006, Annals of Surgical Oncology.

[18]  O. Beahrs.  The American Joint Committee on Cancer. , 1984, Bulletin of the American College of Surgeons.